Spyre Therapeutics
SYRE
#5743
Rank
A$1.33 B
Marketcap
$22.09
Share price
-5.36%
Change (1 day)
-55.63%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -A$0.32 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.33 Billion62.23%
2023 -A$0.21 Billion51.64%
2022 -A$0.14 Billion29.14%
2021 -A$0.11 Billion-19.43%
2020 -A$0.13 Billion1.43%
2019 -A$0.13 Billion76.7%
2018 -A$71.06 Million64.27%
2017 -A$43.26 Million26.34%
2016 -A$34.24 Million93.6%
2015 -A$17.69 Million27.08%
2014 -A$13.92 Million